MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.
NCT ID: NCT01547481
Last Updated: 2018-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2011-12-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating Inhibitory Control Networks in Parkinson's Disease
NCT04735458
Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
NCT04061135
Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
NCT01888185
Neuroimaging Studies of Depression in Parkinson's Disease
NCT00518258
Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.
NCT02132052
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's Disease Cohort
Individuals Diagnosed with Parkinson's Disease
No interventions assigned to this group
Essential Tremor cohort
Individuals Diagnosed with Essential Tremor
No interventions assigned to this group
Rapid Eye Movement Disorder Cohort
Individuals Diagnosed with Rapid-Eye Movement Behavior Disorder (RBD). Eligible individuals will have been diagnosed with RBD based on a sleep study prior to entering the study. This study does not pay for or support a sleep study.
No interventions assigned to this group
Healthy Control group
Individuals are healthy, without a known neurologic disease.
No interventions assigned to this group
Progressive Supranuclear Palsy Cohort
Individuals diagnosed with Progressive Supranuclear Palsy (PSP).
No interventions assigned to this group
Parkinsonism - Undifferentiated
Individuals with any form of Parkinsonism, not meeting any of the above cohorts.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Parkinson Disease (PD) Age 35-85
Diagnosis of clinically definite PD made by a movement disorders specialist, with evidence of the following features:
* Presence of bradykinesia and 1 or both of the following:
1. Rest tremor
2. Rigidity
* Asymmetric Onset
* Progressive motor symptoms
* Levodopa responsive
* Duration at least 1 but not more than 10 years
* Hoehn and Yahr Stage 1-2
Progressive Supranuclear Palsy (PSP) Age 40-85
Diagnosis of clinically definite PSP, with the following features:
* Gradually progressive disorder.
* Onset after age 39
* Supranuclear palsy\* and postural instability with falls in the first year of disease onset\*.
* No evidence of other disease.
Parkinsonism of Other or Undetermined Cause (POC) Age 35-85
Diagnosis of parkinsonism of undetermined other other cause by a movement disorders specialist, with the following features:
* Signs and symptoms of Parkinsonism including
1. Bradykinesia
2. Mixed or resting tremor
3. Rigidity
4. Characteristic deficits of gait and balance associated with Parkinsonism
Essential Tremor (ET) Age 35-85
Diagnosis of essential tremor, with the following features:
* A 2+ postural tremor of at least 1 arm (a head tremor may also be present, but is not sufficient for diagnosis)
* On examination, there must be
1. a 2+ kinetic tremor during at least 4 tasks, or;
2. a 2+ kinetic tremor on 1 task and a 3+ kinetic tremor on a second task; tasks include pouring water, using a spoon to drink water, drinking water, finger-to-nose, and drawing a spiral
* If on examination, the tremor is present in the dominant hand, then by report, it must interfere with at least 1 activity of daily living.
REM Behavior Disorder (RBD) Age 25 - 85
Documented diagnosis of REM sleep behavior disorder (RBD) by a sleep medicine specialist, with the following clinical features:
* Presence of REM sleep without atonia on polysomnography
* At least one of the following conditions:
1. Sleep-related, behaviors by history (eg, dream enactment behavior)
2. Abnormal REM sleep behavior documented during PSG monitoring
Exclusion Criteria
* Pregnancy
* First-degree blood relative affected by PD
* Neurodegenerative disease
* History of repeated head injury, encephalitis, brain surgery, stroke, dementia, neuroleptic exposure, or serious medical illness that may interfere with participation.
Parkinson Disease (PD)
* Atypical features indicative of a Parkinson-Plus disorder
Progressive Supranuclear Palsy (PSP)
* Any finding atypical for PSP
* Neuroradiologic evidence of relevant structural abnormality unrelated to appropriate changes known to be associated with PSP
Parkinsonism of Other or Undetermined Cause (POC)
* Signs and symptoms suggestive of clear diagnosis of idiopathic Parkinson disease, Progressive Supranuclear Palsy, or Essential Tremor
Essential Tremor (ET)
* No other potential etiologic factors for the tremor
* Any first-degree blood relative affected by PD
* History of neurodegenerative disease
REM Behavior Disorder (RBD)
* Sleep disorder not better explained by another sleep disorder, medical or neurological disorder, mental disorder, medication use, or substance use disorder
19 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Frank Michael Skidmore
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frank Skidmore, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
fMRI - Skidmore
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.